ProfessorParesh Malhotra

I am Head of the Division of Neurology in the Department of Brain Sciences, Honorary Consultant Neurologist at Imperial College Healthcare NHS Trust and Deputy Director of the NIHR Imperial Biomedical Research Centre. My undergraduate training was in Oxford, and I subsequently carried out a PhD with Professor Masud Husain at Imperial and the UCL Institute of Cognitive Neuroscience. Following this I completed Specialist Training and a NIHR Clinical Lectureship in London, before a Visiting Scholarship to Sydney with Professors Simon Lewis and John Hodges.

My work focusses on the cognitive deficits that are caused by Neurological conditions such as stroke and neurodegeneration, and developing treatments for these diseases. I am actively involved in the development and assessment of novel treatments. I have carried out a number of interventional studies in stroke patients with impaired attention, and was the lead investigator for a NIHR-funded treatment trial for Alzheimer's Disease.

I am involved in a number of collaborations, both within and outside Imperial College-these include studies assessing multiple biomarkers in the earliest stages of Alzheimer's Disease and other dementias. In addition, I am a Group Leader at the UK Dementia Research Institute, based at the Care Research and Technology Centre, and am also part of the ACORD collaboration to develop novel trial designs for dementia and neurodegeneration. With colleagues from across the country, I am developing a platform trial for symptomatic Alzheimer's Disease.

I have appeared on Sky News, ITV News and the BBC to discuss recent developments in the field of dementia. Work that I have led and been involved in has been reported in The Times, The Guardian, The Daily Telegraph and wider international press.

Current and recent support for my research has come from the Alzheimer's Society, the National Institute of Health Research, the Medical Research Council, and the Biomedical Research Centre at Imperial College. I am the National Specialty lead for Dementia and Neurodegeneration for the NIHR Research Delivery Network and a Trustee of the Alzheimer's Society.